Publicaciones en colaboración con investigadores/as de Johns Hopkins University (23)

2024

  1. A road map for the treatment of pediatric diffuse midline glioma

    Cancer Cell

  2. Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors

    Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 3

2023

  1. Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

    Annals of Epidemiology, Vol. 77, pp. 1-12

2021

  1. The urgent need for public health preparedness funding and support

    American Journal of Public Health, Vol. 111, Núm. 3, pp. 363-365

2020

  1. Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors

    Annals of Oncology, Vol. 31, Núm. 2, pp. 274-282

2017

  1. Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy

    Open Heart, Vol. 4, Núm. 2

  2. Maternal BMI at the start of pregnancy and offspring epigenome-wide DNA methylation: Findings from the pregnancy and childhood epigenetics (PACE) consortium

    Human Molecular Genetics, Vol. 26, Núm. 20, pp. 4067-4085

2016

  1. DNA Methylation in Newborns and Maternal Smoking in Pregnancy: Genome-wide Consortium Meta-analysis

    American Journal of Human Genetics, Vol. 98, Núm. 4, pp. 680-696

  2. Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome

    Nature Communications, Vol. 7

  3. MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents

    Oncogene, Vol. 35, Núm. 45, pp. 5905-5915

2015

  1. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

    Journal of the National Cancer Institute, Vol. 107, Núm. 12

  2. Characterization of large structural genetic mosaicism in human autosomes

    American Journal of Human Genetics, Vol. 96, Núm. 3, pp. 487-497

  3. Enhancing T cell performance against cancer in combination treatment strategies

    Cancer Drug Discovery and Development (Humana Press Inc.), pp. 245-258

  4. Functionally defined therapeutic targets in diffuse intrinsic pontine glioma

    Nature Medicine, Vol. 21, Núm. 6, pp. 555-559

  5. Fundamental Roles of the Golgi-Associated Toxoplasma Aspartyl Protease, ASP5, at the Host-Parasite Interface

    PLoS Pathogens, Vol. 11, Núm. 10

  6. Melanoma: From incurable beast to a curable bet. The success of immunotherapy

    Frontiers in Oncology, Vol. 5, Núm. JUN

2014

  1. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

    Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633

  2. Model for in vivo assessment of humoral protection against malaria sporozoite challenge by passive transfer of monoclonal antibodies and immune serum

    Infection and Immunity, Vol. 82, Núm. 2, pp. 808-817

  3. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma

    Cancer Cell, Vol. 25, Núm. 6, pp. 735-747

2011

  1. Defining the critical hurdles in cancer immunotherapy

    Journal of Translational Medicine